A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

NCT05364931 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Interventions

DRUG: Cotadutide
DRUG: Placebo

Sponsor

AstraZeneca